7-(3-fluoro-4-(1-hydroxy-2-methylpropan-2-ylcarbamoyl)phenyl)-N-(2-fluoro-5-(1-hydroxy-2-methylpropan-2-ylcarbamoyl)phenyl)imidazo[1,2-a]pyridine-3-carboxamide | 1426531-94-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 7-(3-fluoro-4-(1-hydroxy-2-methylpropan-2-ylcarbamoyl)phenyl)-N-(2-fluoro-5-(1-hydroxy-2-methylpropan-2-ylcarbamoyl)phenyl)imidazo[1,2-a]pyridine-3-carboxamide
• 英文别名: N-[2-fluoro-5-[(1-hydroxy-2-methylpropan-2-yl)carbamoyl]phenyl]-7-[3-fluoro-4-[(1-hydroxy-2-methylpropan-2-yl)carbamoyl]phenyl]imidazo[1,2-a]pyridine-3-carboxamide
• CAS: 1426531-94-3
• 化学式: C₃₀H₃₁F₂N₅O₅
• 分子量: 579.603
• InChiKey: XQSIZSQYQYBLKN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  42
• 可旋转键数：
  9
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  145
• 氢给体数：
  5
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  7-(3-fluoro-4-(1-hydroxy-2-methylpropan-2-ylcarbamoyl)phenyl)-N-(2-fluoro-5-(1-hydroxy-2-methylpropan-2-ylcarbamoyl)phenyl)imidazo[1,2-a]pyridine-3-carboxamide 在 水 、 sodium hydroxide 作用下， 以 乙二醇二甲醚 为溶剂， 反应 1.0h， 生成 4-fluoro-3-(7-(3-fluoro-4-(1-hydroxy-2-methylpropan-2-ylcarbamoyl)phenyl)imidazo[1,2-a]pyridine-3-carboxamido)benzoic acid
  参考文献：
  名称：

  [EN] BICYCLIC HETEROCYCLE DERIVATIVES FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
  [FR] DÉRIVÉS HÉTÉROCYCLIQUES BICYCLIQUES POUR LE TRAITEMENT D'UNE HYPERTENSION ARTÉRIELLE PULMONAIRE

  摘要：

  具有式(I)的二环杂环衍生物，可用于抑制血小板衍生生长因子受体介导的生物活性。其中A、R1、R1a、R2、R3、R4、R5、R6和X如本文所定义。

  公开号：

  WO2013030802A1

文献信息

• BICYCLIC HETEROCYCLE DERIVATIVES FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
  申请人：Bruce Ian

  公开号：US20150025059A1

  公开（公告）日：2015-01-22

  Bicyclic heterocyclic derivatives of formula I useful in inhibiting PDGF receptor mediated biological activity. wherein A is and R 1 , R 1a , R 2 , R 3 , R 4 , R 5 , R 6 and X are as defined herein.

  公式I中的双环杂环衍生物可用于抑制PDGF受体介导的生物活性，其中A为，R1，R1a，R2，R3，R4，R5，R6和X如本文所定义。
• Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
  申请人：Bruce Ian

  公开号：US08883819B2

  公开（公告）日：2014-11-11

  Bicyclic heterocyclic derivatives of formula I useful in inhibiting PDGF receptor mediated biological activity. wherein A is and R1, R1a, R2, R3, R4, R5, R6 and X are as defined herein.

  公式I中的双环杂环衍生物对抑制PDGF受体介导的生物活性有用。其中A为，R1，R1a，R2，R3，R4，R5，R6和X的定义如下。
• Cross-linking agents containing isocyanate groups for nitrile rubbers
  申请人：Brandau Sven

  公开号：US10597467B2

  公开（公告）日：2020-03-24

  By the use of special cross-linkers that contain at least two isocyanate groups, hydroxyl group-containing optionally hydrogenated nitrile rubber polymers can be successfully cross-linked. Preferred cross-linkers contain allophanate, biuret, uretdione, uretonimine, bridged carbamate, carbodiimide, isocyanurate, iminooxadiazinedione or oxadiazinetrione structural elements.

  通过使用至少含有两个异氰酸酯基团的特殊交联剂，可成功交联含有羟基的可选氢化丁腈橡胶聚合物。首选的交联剂包含异羧酸盐、双脲酸盐、脲二酮、脲亚胺、桥接氨基甲酸酯、碳化二亚胺、异氰尿酸盐、亚胺氧二嗪二酮或氧二嗪三酮结构元素。
• CROSS-LINKING AGENTS CONTAINING ISOCYANATE GROUPS FOR NITRILE RUBBERS
  申请人：Brandau Sven

  公开号：US20130237667A1

  公开（公告）日：2013-09-12

  By the use of special cross-linkers that contain at least two isocyanate groups, hydroxyl group-containing optionally hydrogenated nitrile rubber polymers can be successfully cross-linked. Preferred cross-linkers contain allophanate, biuret, uretdione, uretonimine, bridged carbamate, carbodiimide, isocyanurate, iminooxadiazinedione or oxadiazinetrione structural elements.
• PHOTOCHROMIC POLYDIORGANOSILOXANE VINYLIC CROSSLINKERS
  申请人：Alcon Inc.

  公开号：US20210284778A1

  公开（公告）日：2021-09-16

  The invention provides a class of photochromic polydiorganosiloxane vinylic crosslinkers. Each of the photochromic polydiorganosiloxane vinylic crosslinkers of the invention comprise (1) a polydiorganosiloxane polymer chain comprising dimethylsiloxane units and photochromic siloxane unit having one methyl substituent and one organic substituent having a photochromic moiety that capable of undergoing a reversible color change upon exposure to UV-irradiation or high-energy-violet light; (2) two terminal ethylenically-unsaturated groups. The invention also provides a soft photochromic contact lens, especially a photochromic silicone hydrogel contact lens, which comprises a crosslinked polymeric material comprising repeating units of at least one of such a class of photochromic polydiorganosiloxane vinylic crosslinkers. The invention further provides a method of producing a photochromic contact lens from a polymerizable composition comprising at least one of such a class of photochromic polydiorganosiloxane vinylic crosslinkers.